Using a genetically modified form of the HIV virus, a team
of University of Nebraska-Lincoln scientists has developed a promising new
approach that could someday lead to a more effective HIV vaccine.
The team, led by chemist Jiantao Guo, virologist Qingsheng
Li and synthetic biologist Wei Niu, has successfully tested the novel approach
for vaccine development in vitro and has published findings in the
international edition of the German journal Angewandte Chemie.